Advanced Search
LETTERS TO THE EDITOR
Korean J Pediatr 2018 February;61(2) :68-69.
Published online 2018 February 15.       
B-type natriuretic peptide may have a role in the management of patent ductus arteriosus
Jang Hoon Lee
Department of Pediatrics, Ajou Univerisity School of Medicine, Suwon, Korea
Corresponding Author: Jang Hoon Lee ,Tel: +82-31-219-5160, Fax: +82-31-219-5169, Email: neopedlee@gmail.com
Copyright © 2018 by The Korean Pediatric Society
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
  Print
Share:      
METRICS
363
View
34
Download
Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants  2017 June;60(6)
Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus  2016 April;59(4)
N-terminal Pro-B-type Natriuretic Peptide as a Predictive Risk Factor in Fontan Operation  2005 December;48(12)
Usefulness of Plasma Atrial Natriuretic Peptide Concentration in the Diagnosis of Patent Ductus Arteriosus in Preterm Infants  2000 July;43(7)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.